...
首页> 外文期刊>Journal of Experimental Zoology India >STUDIES ON EVALUATION OF HYPOGLYCEMIC EFFECT OF AQUEOUS EXTRACT OF ALOE VERA IN STREPTOZOTOCIN INDUCED DIABETIC RATS
【24h】

STUDIES ON EVALUATION OF HYPOGLYCEMIC EFFECT OF AQUEOUS EXTRACT OF ALOE VERA IN STREPTOZOTOCIN INDUCED DIABETIC RATS

机译:芦荟水提取物在链脲佐菌素诱导糖尿病大鼠中对降血糖效应评价的研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hypoglycemic effect of aqueous extract ofAloe vera (L.) Burm.f. was evaluated in streptozotodn induced diabetic nits. Diabetes was induced in Wister albino female rats experimentally by using Streptozotodn at the dose rate of 40 mg/kg. The various groups in this study included normal control (Group I), diabetic control (Group II), diabetic rats treated with glibenclamide at the dose of600 mg/kg (Group III), diabetic rats treated with Aloe vera at the dose of300 mg/kg (Group IV) and diabetic rats treated with com bination of Aloe vera (150 mg/kg) and glibenclamide (300 mg/kg) (Group V). By estimating the serum glucose levels 72 hours post STZ injection the diabetes was confirmed. The serum samples were collected at various intervals and subjected forthe estimation of glucose using biochemical analyzer. The serum glucose values in diabetic control ' rats were significantly higher (P< 0.001) on all the intervals of study in comparison with normal control rats. The mean (± SE) serum glucose levels inthe diabetic rats treated with Glibenclamide at the dose of600 mg/kg body weight showed a gradual and significant reduction (P< 0.001) from day 3 to day 45 when compared to diabetic control rats. There was a progressive decrease in the mean (± SE) serum glucose values in the diabetic rats treated with Aloe vera individually and in Aloe vera & Glibenclamide combined treatment group. However, the combined treatment of Aloe vera (150 mg/kg) with glibenclamide (300 mg/kg) revealed better hypoglycemic effect which indicated a synergistic effect of Aloe vera and glibenclamide when used in combination.
机译:aloe Vera(L.)毛刺水质提取物的降血糖作用。在Streptozozodn诱导的糖尿病尼西茨评估。通过使用40mg / kg的剂量率使用链霉ocododn实验在实验中在Wists Albino雌性大鼠中诱导糖尿病。本研究中的各组包括正常对照(Ⅰ组),糖尿病对照(II族),用Glibenclamide治疗的糖尿病大鼠在600mg / kg(III族),用芦荟治疗的剂量为300 mg / KG(IV组)和用芦荟(150mg / kg)和Glibenclamide(300mg / kg)(V)的COM间距处理的糖尿病大鼠。通过估计血清葡萄糖水平72小时后,STZ注射后糖尿病被证实。以各种间隔收集血清样品,并使用生物化学分析仪进行葡萄糖的估计。与正常对照大鼠相比,糖尿病控制大鼠大鼠大鼠大鼠大鼠血清葡萄糖值显着高(P <0.001)。与糖尿病对照大鼠相比,用Glibenclamide处理的糖尿病大鼠用Glibenclamide处理的糖尿病大鼠的糖尿病大鼠逐渐减少(p <0.001),与糖尿病对照大鼠相比,45天。在芦荟可单独和芦荟和Glibenclamide联合治疗组中使用芦荟治疗的糖尿病大鼠糖尿病大鼠中的平均值(±SE)血清葡萄糖值逐渐降低。然而,芦荟(150mg / kg)与Glibenclamide(300mg / kg)的组合治疗揭示了更好的降血糖效应,这表明在组合使用时芦荟和Glibenclamide的协同作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号